Opinion

Video

Empowering Pharmacists: Navigating Pediatric OTC Medications and Building Trust With Parents

Author(s):

Trisha Winroth, PharmD,Ashly McPhillips, PharmD

Key Takeaways

  • Understanding recommended doses and duration of use is essential for effective pediatric medication management.
  • Building rapport and counseling parents are crucial for adherence to treatment plans and addressing concerns.
SHOW MORE

Key opinion leaders provide pharmacists with essential guidance on the appropriate dosing and administration of over-the-counter medications for common pediatric conditions, while equipping them with strategies to effectively counsel parents on symptom identification, condition management, and when to seek medical advice for children's health issues.

00:12 - Recommended Doses

5:24 - Duration of Use

8:43 - Infant Gas

10:12 - Parental Concerns

12:56 - Counseling Parents

15:16 - Building Rapports

18:22 - Safety and Storage

21:49 – Healthy Habits

24:35 - Safety Concerns

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Child with cancer -- Image credit: Alexis Scholtz/peopleimages.com | stock.adobe.com
Female pharmacist assists a patient with their prescriptions.
Yellow ribbon for sarcoma awareness -- Image credit: Jo Panuwat D | stock.adobe.com
Ashley Pugh, PharmD, and Lauren Angelo, PharmD, MBA
Related Content
Early Asthma Onset Associated With Memory and Executive Function Difficulties in Children
November 20th 2024

Early Asthma Onset Associated With Memory and Executive Function Difficulties in Children

Luke Halpern, Assistant Editor
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
Pediatric, FDA, Rare Pediatric Disease Designation, SP-B Deficiency | Image Credit: ©jakkapan | stock.adobe.com
November 18th 2024

FDA Grants Rare Pediatric Disease Designation for Treatment of Neonatal SP-B Deficiency

Ashley Gallagher, Associate Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Newborn baby -- Image credit: annaperevozkina | stock.adobe.com
November 14th 2024

Risk of Psychiatric Disorders Increases for Children of Mothers With Eating Disorder History

Gillian McGovern, Assistant Editor
Bone Cancer, Ewing Sarcoma, Oncology, Pediatric Patients | Image Credit: © Richman Photo | stock.adobe.com
November 13th 2024

FDA Grants Rare Pediatric Disease Designation to Elraglusib for Ewing Sarcoma

Ashley Gallagher, Associate Editor